This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Maat, B. Selective macrophage inhibition abolishes warfarin-induced reduction of metastasis. Br J Cancer 41, 313–316 (1980). https://doi.org/10.1038/bjc.1980.46
Issue Date:
DOI: https://doi.org/10.1038/bjc.1980.46
This article is cited by
-
Anticoagulants and cancer mortality in the Finnish randomized study of screening for prostate cancer
Cancer Causes & Control (2019)
-
Prostate cancer-specific survival among warfarin users in the Finnish Randomized Study of Screening for Prostate Cancer
BMC Cancer (2017)
-
The effect of warfarin therapy on breast, colorectal, lung, and prostate cancer survival: a population-based cohort study using the Clinical Practice Research Datalink
Cancer Causes & Control (2015)
-
The first international urokinase/warfarin trial in colorectal cancer
Clinical & Experimental Metastasis (1991)
-
Hämatologische oder hämostaseologische „Paraneoplasien“ als Prognosefaktoren?
Klinische Wochenschrift (1988)